MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$318,404K
Cash and cash
equivalents
$72,488K
Prepaid expenses and
other current assets
$14,472K
Total property and
equipment
$36,136K
Total current assets
$405,364K
Marketable securities,
long-term
$66,739K
Operating lease
right-of-use assets, net
$17,357K
Property and equipment,
net
$13,587K
Other assets
$9,858K
Less accumulated
depreciation and...
$22,549K
Total assets
$512,905K
Total liabilities and
stockholders equity
$512,905K
Total stockholders
equity
$451,836K
Total liabilities
$61,069K
Accumulated deficit
-$785,064K
Accumulated other
comprehensive gain (loss)
-$180K
Additional
paid-in-capital
$1,237,075K
Total current
liabilities
$43,404K
Operating lease
liabilities, long-term...
$15,049K
Deferred revenue, net of
current portion
$2,125K
Derivative liability
$370K
Other liabilities
$121K
Common stock, 0.0001
par value,...
$5K
Accrued and other
current liabilities
$22,866K
Accounts payable
$14,692K
Operating lease
liabilities, current portion
$5,486K
Deferred revenue
$360K
Back
Back
Balance Sheet
4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT)
source: myfinsight.com